These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1349490)
21. Beta-blockade--selection and use. Heikkilä J; Jounela A; Katila M; Luomanmäki K; Frick MH Ann Clin Res; 1979 Dec; 11(6):267-89. PubMed ID: 44825 [No Abstract] [Full Text] [Related]
22. Other important applications for beta-blockers in high-risk patients. Egan BM; Chilton RJ Postgrad Med; 2003 Dec; 114(6 Suppl Role):35-48. PubMed ID: 19667668 [TBL] [Abstract][Full Text] [Related]
23. [General principles of the use of inhibitors of adrenergic receptors]. Mornex R Cah Med; 1974 Nov; 15(13):817-28. PubMed ID: 4155996 [No Abstract] [Full Text] [Related]
24. [Current problems in the clinical use of beta-adrenergic system blockaders in endocrinology]. Tikhonova EP; Rom-Bugoslavskaia ES; Levchenko TP Probl Endokrinol (Mosk); 1971; 17(1):109-15. PubMed ID: 4398763 [No Abstract] [Full Text] [Related]
25. Beta-blocking drugs--their use in an industrial environment. Millar-Craig MW J Soc Occup Med; 1979 Jul; 29(3):107-11. PubMed ID: 39199 [No Abstract] [Full Text] [Related]
26. [Therapeutic use of beta-blockers in general pathology (rheumatology, neurology and ophthalmology) (author's transl)]. Bouvenot G; Bartolin R; Escande M; Delboy C Therapie; 1980; 35(1):61-81. PubMed ID: 6106303 [No Abstract] [Full Text] [Related]
27. [Cardiovascular pharmacology (IV). The current validity of "old" drugs: beta-blockers]. Permanyer Miralda G; Sanz Girgas E Rev Esp Cardiol; 1994 Sep; 47(9):616-25. PubMed ID: 7973029 [No Abstract] [Full Text] [Related]
28. Beta-adrenergic antagonists: indications and potential immunomodulatory side effects in the critically ill. Oberbeck R; Kobbe P Curr Med Chem; 2009; 16(9):1082-90. PubMed ID: 19275613 [TBL] [Abstract][Full Text] [Related]
30. [Use of propranolol and other beta-adrenolytic drugs in the treatment of nervous system diseases]. Głuszcz-Zielińska A Wiad Lek; 1984 Nov; 37(22):1781-6. PubMed ID: 6152364 [No Abstract] [Full Text] [Related]
32. Clinical aspects of beta-blockade. Smith U Cephalalgia; 1986; 6 Suppl 5():55-7. PubMed ID: 2879633 [TBL] [Abstract][Full Text] [Related]
33. Beta-adrenergic blockers. Frishman WH Med Clin North Am; 1988 Jan; 72(1):37-81. PubMed ID: 2892986 [TBL] [Abstract][Full Text] [Related]
34. The role of β-blockers in dermatological treatment: a review. Chen L; Tsai TF J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):363-371. PubMed ID: 28850731 [TBL] [Abstract][Full Text] [Related]
35. [The use of beta-blocking agents in psychiatry and neurology (author's transl)]. Floru L Fortschr Neurol Psychiatr Grenzgeb; 1977 Feb; 45(2):112-27. PubMed ID: 14067 [TBL] [Abstract][Full Text] [Related]
36. Beta-blocking drugs and psoriasis. A review of cutaneous side effects and retrospective analysis of their effects on psoriasis. Gold MH; Holy AK; Roenigk HH J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):837-41. PubMed ID: 2903871 [TBL] [Abstract][Full Text] [Related]
37. Beta-adrenergic blockade. An update. Frishman WH; Teicher M Cardiology; 1985; 72(5-6):280-96. PubMed ID: 2866839 [TBL] [Abstract][Full Text] [Related]